Zimmer Biomet Holdings, Inc. ZBH
91.04
1.35
1.51%
as of 25 Sep
- Market cap
- $17.1B
- P/E
- 22.0×
Follow ZBH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Zimmer Biomet Holdings, Inc. (ZBH) P/B ratio
As of 25 September 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a P/B ratio of 1.4×. Over the past ten years it has ranged from 1.2× (May 2026) to 3.0× (February 2015); the current reading is higher than 3% of that period. That is below the Medical Devices industry median of 2.5× and below the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 1.4× | (18.51%) |
| FY2024 | 1.7× | (15.23%) |
| FY2023 | 2.0× | (8.55%) |
| FY2022 | 2.2× | 9.20% |
| FY2021 | 2.0× | (19.98%) |
| FY2020 | 2.5× | 5.55% |
| FY2019 | 2.4× | 32.34% |
| FY2018 | 1.8× | (12.30%) |
| FY2017 | 2.1× | (0.13%) |
| FY2016 | 2.1× | 9.93% |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 1.3× | (5.80%) |
| Mar 2026 | 1.4× | (0.78%) |
| Dec 2025 | 1.4× | (8.32%) |
| Sep 2025 | 1.5× | 6.14% |
| 42 more quarters | Free account |
Against its own ten years
Low 1.2×
High 3.0×
Ten-year median
2.1×
Current reading's percentile
3
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| BIO.B Bio-Rad Laboratories, Inc. compare | 1.4× |
| ZBH Zimmer Biomet Holdings, Inc. | 1.4× |
| BIO Bio-Rad Laboratories, Inc. compare | 1.4× |
| PHG Koninklijke Philips N.V. compare | 1.8× |
| GMED Globus Medical, Inc. compare | 2.1× |
| SNN Smith & Nephew SNATS, Inc. compare | 2.3× |
| GEHC GE HealthCare Technologies Inc. compare | 2.7× |
| STE STERIS plc compare | 2.8× |
| PEN Penumbra, Inc. compare | 8.2× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on ZBH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement